Complete Genomics Targets Larger Share of Services Market; Analysts Predict 21K Genomes in 2012 | GenomeWeb

By Monica Heger

This story was originally published June 6.

Complete Genomics is "gaining traction" in the sequencing services business, according to investment firm Jefferies, which resumed coverage of the company today, giving it a 'Buy' rating.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.